65
Participants
Start Date
October 31, 2014
Primary Completion Date
January 31, 2017
Study Completion Date
September 30, 2017
alginate oligosaccharide
Inhalation
Rigshospitalet, Copenhagen
Pediatric Pulmonology and Immunology, Charité Universitätsmedizin, Berlin
Stockholm CF-center, Karolinska Universitetssjukhuset, Stockholm
Klinik für Pneumologie, CF-Ambulanz, Hanover
CF-mottagningen, Sahlgrenska Universitetssjukhuset, Gothenburg
CF Zentrum Köln, Universitätskrankenhaus Köln, Cologne
Medizinische Klinik I, Pneumologie, Uniklinik, Frankfurt
Center for Pediatric Clinical Studies,, Tübingen
Mukoviszidose-Zentrum für Erwachsene, Med. Klinik V-Innenstadt (LMU), Münich
Pneumologische Praxis Pasing, Münich
Oslo University Hospital, Oslo
Regional Respiratory Centre, Belfast City Hospital, Belfast
Papworth Hospital, Cambridge
Bio-Images Research Ltd, Basement Medical Block, Within GRI, Glasgow
Liverpool Heart and Chest Hospital, Liverpool
Royal Brompton and Harefield NHS Foundation Trust, London
Queens Medical Centre, Nottingham
Southampton General Hospital, Southampton
Lead Sponsor
Collaborators (1)
Eurostars
OTHER
Smerud Medical Research International AS
OTHER
AlgiPharma AS
INDUSTRY